The antithrombotic and antimicrobial properties of PEG-protected silver nanoparticle coated surfaces
Source abstract
Abstract
Cardiovascular implant-associated complications such as infection and thrombosis may be reduced by modification of device surfaces using antimicrobial and antithrombotic agents. Silver nanoparticles (SNPs) are well accepted for its broad-spectrum antimicrobial effect. A recent report suggested its antiplatelet effect also. So the hypothesis of this study is that polyethylene glycol (PEG) protected SNPs can be incorporated with biomaterials to attain dual properties; and by adjusting an optimum concentration, its cytotoxicity to tissues and cells can be prevented. To prove this, detailed study of PEG-SNP was done at three levels: (i) direct inhibitory effect on platelet activation, aggregation and biochemical pathways when PEG-SNP is added into platelet suspension; (ii) inhibition of platelet adhesion to PEG-SNP incorporated biological matrix and polymer scaffold and (iii) non-cytotoxic behavior of immobilized PEG-SNP in fibrin matrix. Inhibitory effects demonstrated are on: platelet function by aggregometry, exposure of activation and apoptosis markers by flow cytometry, biochemical pathway by malondealdehyde (MDA) estimation and protein phosphorylation by Western blot. Reduced platelet adhesion onto PEG-SNP incorporated scaffold is shown using scanning electron microscopy (SEM). Non-toxic behavior of endothelial cells (EC) and smooth muscle cells (SMC) grown on PEG-SNP-fibrin disc is shown by fluorescence microscopy and cell phenotype stability by real-time polymerase chain reaction (PCR).
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Graphene and Nanomaterials Applications · Polymer Nanocomposite Synthesis and Irradiation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (19)
Show source-provided references
1. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes10.1016/j.biomaterials.2004.01.023 ↗
2. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation10.1016/j.jacc.2009.12.056 ↗
3. Silver nanoparticle impregnated poly (ɛ-caprolactone) scaffolds: optimization of antimicrobial and noncytotoxic concentrations10.1089/ten.tea.2009.0791 ↗
4. Characterization of antiplatelet properties of silver nanoparticles10.1021/nn900277t ↗
5. Effect of passage number and matrix characteristics on differentiation of endothelial cells cultured for tissue engineering10.1016/j.biomaterials.2005.02.024 ↗
6. Comparative evaluation of absorbable hemostats: advantages of fibrin based sheets10.1016/j.biomaterials.2004.01.013 ↗
7. Protease action and generation of beta-thromboglobulin-like protein followed by platelet activation10.1016/S0049-3848(02)00154-8 ↗
8. Platelet recovery from aspirin inhibition in vivo; differing patterns under various assay conditions10.1182/blood.V57.1.99.99 ↗
9. Adult stem cell homing and differentiation in vitro on composite fibrin matrix10.1111/j.1365-2184.2006.00389.x ↗
10. Development of a fibrin composite-coated poly(epsilon-caprolactone) scaffold for potential vascular tissue engineering applications10.1002/jbm.b.31146 ↗
11. Cytotoxicity and genotoxicity of silver nanoparticles in human cells10.1021/nn800596w ↗
12. Observation of growth of human fibroblast on silver nanoparticles10.1088/1742-6596/61/1/089 ↗
13. Identification of a region of human fibrinogen interacting with staphylococcal clumping factor10.1021/bi00535a047 ↗
14. Reactivity of human platelets with immobilized fibrinogen is dictated by the chemical character of the surface10.1016/S0049-3848(01)00337-1 ↗
15. Endothelial cell growth factor (ECGF) enmeshed with fibrin matrix enhances proliferation of EC in vitro10.1016/S0142-9612(01)00020-5 ↗
16. Platelet morphology, biochemistry and function
17. Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex10.1055/s-0038-1648803 ↗
18. Antiproliferative effect of silver nanaoparticles10.1186/1471-2121-10-65 ↗
19. Rapid Ag+-induced release of Ca2+ from sarcoplasmic reticulum vesicles of skeletal muscle: a rapid filtration study10.1016/0005-2736(89)90295-2 ↗